Acclaimed Cardiology Expert Dr. Peter Libby To Keynote 19th Annual CMHC, Revolutionize Atherosclerosis Care
May 22 2024 - 11:00AM
The Cardiometabolic Health Congress (CMHC) is proud to
announce that one of the foremost authorities in atherosclerosis,
Peter Libby, MD, will deliver the keynote address at its upcoming
19th annual conference, DECODING THE CONSTELLATION of
Cardiometabolic Health and Risk Factors Oct. 17-19, 2024, at The
Boston Park Plaza, MA.
Dr. Peter Libby is a cardiovascular medicine specialist at
Brigham and Women's Hospital (BWH) and the Mallinckrodt Professor
of Medicine at Harvard Medical School. A world-renowned author and
lecturer on cardiovascular medicine and atherosclerosis, Dr. Libby
has been published extensively in leading medical journals. He led
the pivotal Canakinumab Anti-Inflammatory Thrombosis Outcomes
Trial (CANTOS), which clinically validated the role of
inflammation in atherosclerosis. Dr. Libby has been awarded the
2024 Valentin Fuster Award for Innovation in Science for his
leadership and innovative work in this field.
Insights from a Leading Expert in
Atherosclerosis
Dr. Peter Libby's keynote, "Prevention and Treatment of
Atherosclerosis," at the 19th Annual CMHC conference will
provide an update on his research on inflammation and
atherosclerosis. He will also present practical approaches for
targeting and treating inflammation in everyday clinical
practice.
"It is gratifying to have the work we started on inflammation
and immunity in atherosclerosis so many years ago being recognized
and becoming actionable for our patients," says Dr.
Libby.
Dr. Libby acknowledges significant strides in treating
individual cardiometabolic conditions. However, cardiovascular
disease, diabetes, kidney disease, and liver disease remain among
the most pervasive chronic conditions in the US.
His keynote address will set the tone for the conference, where
attendees will explore how diseases across the cardiometabolic
spectrum share common roots and affect related organs, increasing
overall systemic stress. It will specifically underscore that a
single cardiometabolic condition raises the risk of others and the
likelihood of poor health outcomes.
About the 19th Annual Cardiometabolic Health Congress
(CMHC)
As The Cardiometabolic Event of the Yearâ„¢, DECODING THE
CONSTELLATION of Cardiometabolic Health and Risk Factors will focus
on critical clinical considerations and trending topics in
cardiorenal and cardiometabolic health. This year's conference will
particularly address the overlapping, interconnected constellations
of cardiometabolic conditions that challenge current care
models.
The medical education conference will span three days and
feature:
- Didactic lectures
- Expert panel debates
- Real-patient case discussions
- Prize giveaways
- Professional development opportunities
- Industry access and networking
Join Dr. Peter Libby, many other celebrated faculty experts, and
colleagues at the historic Boston Park Plaza from October 17-19,
2024. To register for the 19th Annual CMHC,
click here or visit www.cardiometabolichealth.org/19th-annual-cmhc/.
#####
Cardiometabolic Health Congress (CMHC) is a single point of
access for breakthrough research, comprehensive education, and
practical clinical strategies surrounding cardiometabolic health.
First launched in 2006, the Annual CMHC is now the largest
U.S.-based, multidisciplinary conference addressing cardiometabolic
disease prevention, management, and treatment. Since its inception,
CMHC has expanded to deliver extensive online education, advanced
masterclass workshops, and various cutting-edge resources.
Developed and led by world-renowned experts in the field, CMHC
serves to optimize patient care and population health outcomes by
providing top-tier continuing medical education that targets the
global epidemic of cardiometabolic disease.
Zuzanna Walter, Content Director | Informa Medical
Cardiometabolic Health Congress
5619970112
zuzanna.walter@informa.com